Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases

Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases

Abstract Background Because atopic dermatitis does not heal completely, associated severe atopic keratoconjunctivitis (AKC) and vernal keratoconjunctivitis (VKC) often require long-term treatment. This study aims to evaluate the long-term outcomes of using 0.1% tacrolimus eye drops to treat these se...

Full description

Bibliographic Details
Main Authors: Hiroyuki Yazu, Kazumi Fukagawa, Eisuke Shimizu, Yasunori Sato, Hiroshi Fujishima
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Tacrolimus
Atopic keratoconjunctivitis
Vernal keratoconjunctivitis
Objective sign
Steroid
Intraocular pressure
Online Access:https://doi.org/10.1186/s13223-021-00513-w

Internet

https://doi.org/10.1186/s13223-021-00513-w

Similar Items